No Carolina / NY / Florida
Ph: 561.316.3330

No Carolina | NY | Florida

Violet Defense Offers Affordable Disinfection as a Service to Respond to COVID-19 Surges

UV disinfection products safely kill COVID-19, flu, and Norovirus to protect people, industries, and the environment

Editor: What To Know

  • With that in mind, Violet Defense is developing a new business model, Disinfection as a Service, where businesses can install its UV disinfection products via a lease-style arrangement, making it an operating expense instead of a capital purchase.
  • “Superior disinfection practices are not a luxury to aspire to anymore, they are a necessity, and UV disinfection is a proven way to keep people safe.
  • Violet Defense, a UV disinfection technology company, provides a better, sustainable, and long-term solution that is now available as a service.

Violet Defense notes as the Omicron coronavirus variant sweeps the country and COVID-19 cases surge, many businesses are trying to ride it out with standard or even diminished precautions.

Violet Defense, a UV disinfection technology company, provides a better, sustainable, and long-term solution that is now available as a service.

Violet Defense is the developer of patented ultraviolet (UV) light technology proven in laboratory tests to kill bacteria and viruses, including coronavirus, norovirus, E. coli, C. diff, C. auris, Salmonella and MRSA. Its pulsed Xenon solution can be permanently installed or used in portable units.

Public-serving organizations are trying to remain open during the latest coronavirus resurgence, using standard chemical disinfection methods that have been insufficient and put workers at risk. Meanwhile, employees and customers are less often using precautions like social distancing and masks. That translates to increased risk of infection.

“The rapid spread of the latest COVID-19 variant has shown clearly that we don’t have the proper protections in place,” said Violet Defense CEO Terrance Berland. “Superior disinfection practices are not a luxury to aspire to anymore, they are a necessity, and UV disinfection is a proven way to keep people safe.”

Schools, hospitals, and all types of businesses are struggling to stay open as large numbers of employees become ill and quarantine. Even after the coronavirus pandemic subsides, illnesses like influenza will pose the same problem. That reminds us that vaccination, rapid testing and contact tracing alone cannot keep the public safe – frequent, thorough and effective disinfection is also vital.

With that in mind, Violet Defense is developing a new business model, Disinfection as a Service, where businesses can install its UV disinfection products via a lease-style arrangement, making it an operating expense instead of a capital purchase. The small Violet Defense unit would cost little more than $1 per disinfection cycle.

“We have a responsibility to protect our children, first responders, teachers, business owners – everyone. In that sense, disinfection is essentially a public service,” Berland said. “With Violet Defense’s new program, it’s an easy choice to get the best disinfection possible – at little more than $1 per disinfection cycle, how can you afford not to?”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Recent News

CV Societies Propel Plans Forward for a New Board of Cardiovascular Medicine

“The open comment period is the time for cardiovascular physicians, allies in other medical specialties, patients, and others to make their voices heard on why an independent CV Board is the best path for cardiologists to stay up-to-date on best practices and evidence-based care, ensuring patients receive the best possible care,” said Jeffrey Kuvin, MD, president of the proposed Board’s new Board of Directors. “The field of cardiovascular medicine has evolved dramatically over the past few decades; now is the right time to develop an independent cardiovascular Board.”

Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer

Sang-ki Oh, CEO of Hyundai Bioscience, stated, "Niclosamide-based metabolic anticancer drug candidate will be the first P53-targeting anticancer treatment that selectively kills p53 mutated cancer cells," and added, "Through our subsidiary ADM Korea, we plan to conduct clinical trials targeting cancer patients with intractable cancer caused by p53 mutations, which will be the first step of clinical development on niclosamide-based anticancer agent pipeline."

Sedana Medical Completes Patient Recruitment for INSPiRE-ICU 1 Clinical Trial in the US

Peter Sackey further elaborated: "Once the 30-day follow-up of all patients is complete, we will enter into an intense phase of final monitoring, data cleaning and transfer to our statistician team for analysis. In parallel, the long-term outcomes at 3 and 6 months will be collected centrally by the Critical Illness, Brain Dysfunction, and Survivorship team at Vanderbilt Medical Center. With this parallel approach, we expect topline results in the autumn of this year and a swift regulatory submission in Q1, 2025".

Health / Lifestyle

Articles of Interest

Stay Connected

spot_img

About Medical Device News Magazine

About Medical Device News Magazine. A digital publication founded in 2008 located in the United States. The publication is one of the industry’s leading sources of medical device and biotech industry updates. Medical Device News Magazine is easily accessible 24/7/365 and is a fast 1, 2, 3 easy read! Our purpose is...

By using this website you agree to accept Medical Device News Magazine Privacy Policy